Respiratory Activities
Evaluating Current Therapies for Idiopathic Pulmonary Fibrosis
0290-0000-18-149-H01-P
After attending this PTCE program, participants will be able to identify IPF treatment options for cost-effective disease management when selecting drug therapy.
1.50
The Pharmacist's Opportunity to Improve Disease-State Management in Cystic Fibrosis
0290-0000-18-136-H01-P
Participants will gain understanding of the current treatment options for cystic fibrosis and the role of the pharmacist in improving patient adherence and outcomes.
1.50
New and Emerging Treatments for the Care of Patients with EGFR- and ALK-Positive NSCLC
0290-0000-18-111-H01-P
This presentation will review progress made in developing personalized therapeutic approaches to the management of NSCLC, the most common form of lung cancer.
1.00
Optimized Care of Patients With COPD: Pharmacotherapy and Appropriate Use of Inhalers
0290-0000-18-051-H01-P
The faculty panel of this PTCE program will discuss pharmacologic agents in COPD management and other important topics pertaining to COPD.
1.50